ANBC Income Statement | StatInvestor

Health Care & Life Sciences » Pharmaceuticals | ANBC Inc.

ANBC Inc. | Income Statement

Fiscal year is January-December. All values USD Thousands.

2016

Sales/Revenue

2,867.70

Cost of Goods Sold (COGS) incl. D&A

1,497.80

Gross Income

1,369.90

SG&A Expense

127.70

EBIT

1,242.20

Interest Expense

0.30

Pretax Income

1,242.00

Income Tax

30.50

Consolidated Net Income

1,211.50

Net Income

1,211.50

Net Income After Extraordinaries

1,211.50

Net Income Available to Common

1,211.50

EPS (Basic)

0.06

Basic Shares Outstanding

21,605.00

EPS (Diluted)

0.06

Diluted Shares Outstanding

21,605.00

EBITDA

1,355.40

Non-Operating Interest Income

0.10

View Profile

Address	No. 2020 Huqingping Road Shanghai Shanghai 201702 China
Employees	-
Website	-
Updated	07/08/2019
ANBC, Inc. manufactures and processes healthcare products through its subsidiary Shanghai Niubeile Biotechnology Co., Ltd. Its activities include production of capsule, food circulation and sales of food additives. The company was founded on January 16, 2006 and is headquartered in Shanghai, China. .